Effect of a strong desire to void on walking speed in individuals with multiple sclerosis and urinary disorders / Claire Hentzen in Annals of physical and rehabilitation medicine, Vol. 63, n°2 (Mars 2020)

Public ISBD [article]  inAnnals of physical and rehabilitation medicine > Vol. 63, n°2 (Mars 2020) . - p. 106-110 Titre : Effect of a strong desire to void on walking speed in individuals with multiple sclerosis and urinary disorders Type de document : texte imprimé Auteurs : Claire Hentzen ; Nicolas Trumel ; Camille Chesnel ; Audrey Charlanes ; Frédérique Le Breton ; Samer Sheikh Ismaël ; Gérard Amarenco Année de publication : 2020 Article en page(s) : p. 106-110 Note générale : doi.org/10.1016/j.rehab.2019.11.007 Langues : Anglais (eng) Mots-clés : Multiple sclerosis  Walking speed  Gait  Urination  Lower urinary tract symptoms Résumé : Background Lower urinary tract symptoms, especially overactive bladder, are frequent and disabling in individuals with multiple sclerosis (IwMS). An association with gait disorders is common, which could aggravate continence difficulties and affect quality of life. The association between the need to void and walking has never been studied in this population. Objective The primary aim of this study was to assess the effect of a strong desire to void (SDV) on walking speed in IwMS and lower urinary tract symptoms. The secondary aim was to identify clinical or urodynamic factors associated with walking speed impairment at SDV in this population. Methods We included IwMS with urinary disorders and Expanded Disability Status Scale score < 7 in this observational study. Individuals underwent 3 10-m walk tests (10MWT) and one Timed Up and Go (TUG) test at SDV and at post-void (PV). Results Among the 72 IwMS included (mean [SD] age 50.6 [11.6] years; 46 [64%] females), the mean (SD) speed for 10MWT was 1.00 (0.31) m.s−1 at SDV and 1.07 (0.30) m.s−1 at PV (P < 0.0001). Time for TUG was also increased when individuals felt SDV: mean 11.53 (4.6) sec at SDV versus 10.77 (3.8) sec at PV (P = 0.004). No predictors of greater impairment of walking speed at SDV were identified. Conclusion This study suggests a clinical impact of bladder sensation on walking speed in IwMS and urinary disorders. None of the individual characteristics could predict greater decrease in gait velocity at SDV. Permalink : ./index.php?lvl=notice_display&id=90779 [article] Effect of a strong desire to void on walking speed in individuals with multiple sclerosis and urinary disorders [texte imprimé] / Claire Hentzen ; Nicolas Trumel ; Camille Chesnel ; Audrey Charlanes ; Frédérique Le Breton ; Samer Sheikh Ismaël ; Gérard Amarenco . - 2020 . - p. 106-110. doi.org/10.1016/j.rehab.2019.11.007 Langues : Anglais (eng) in Annals of physical and rehabilitation medicine > Vol. 63, n°2 (Mars 2020) . - p. 106-110 Mots-clés : Multiple sclerosis  Walking speed  Gait  Urination  Lower urinary tract symptoms Résumé : Background Lower urinary tract symptoms, especially overactive bladder, are frequent and disabling in individuals with multiple sclerosis (IwMS). An association with gait disorders is common, which could aggravate continence difficulties and affect quality of life. The association between the need to void and walking has never been studied in this population. Objective The primary aim of this study was to assess the effect of a strong desire to void (SDV) on walking speed in IwMS and lower urinary tract symptoms. The secondary aim was to identify clinical or urodynamic factors associated with walking speed impairment at SDV in this population. Methods We included IwMS with urinary disorders and Expanded Disability Status Scale score < 7 in this observational study. Individuals underwent 3 10-m walk tests (10MWT) and one Timed Up and Go (TUG) test at SDV and at post-void (PV). Results Among the 72 IwMS included (mean [SD] age 50.6 [11.6] years; 46 [64%] females), the mean (SD) speed for 10MWT was 1.00 (0.31) m.s−1 at SDV and 1.07 (0.30) m.s−1 at PV (P < 0.0001). Time for TUG was also increased when individuals felt SDV: mean 11.53 (4.6) sec at SDV versus 10.77 (3.8) sec at PV (P = 0.004). No predictors of greater impairment of walking speed at SDV were identified. Conclusion This study suggests a clinical impact of bladder sensation on walking speed in IwMS and urinary disorders. None of the individual characteristics could predict greater decrease in gait velocity at SDV. Permalink : ./index.php?lvl=notice_display&id=90779

Exemplaires (1)

Cote	Support	Localisation	Section	Disponibilité
Revue	Revue	Centre de Documentation HELHa Campus Montignies	Armoires à volets	Document exclu du prêt - à consulter sur place Exclu du prêt

French clinical guidelines for peripheral motor nerve blocks in a PRM setting / Alain P. Yelnik in Annals of physical and rehabilitation medicine, Vol. 62, n°4 (Juillet 2019)  

Public ISBD [article]  inAnnals of physical and rehabilitation medicine > Vol. 62, n°4 (Juillet 2019) . - p. 252-264 Titre : French clinical guidelines for peripheral motor nerve blocks in a PRM setting Type de document : texte imprimé Auteurs : Alain P. Yelnik ; Claire Hentzen ; Philippe Cuvillon ; Etienne Allart ; Isabelle V. Bonan ; François C. Boyer ; Flavia Coroian ; Éric Viel (1931-2008) Année de publication : 2019 Article en page(s) : p. 252-264 Note générale : https://doi.org/10.1016/j.rehab.2019.06.001 Langues : Anglais (eng) Mots-clés : Motor nerve block  Physical and rehabilitation medicine  Spasticity  Rehabilitation Résumé : Introduction Motor nerve blocks with anesthetic drug for local anesthesia are commonly used in physical and rehabilitation medicine (PRM), especially in the field of spasticity. Guidelines in this context are currently lacking. Method Eighteen experts selected on the basis of their recognized experience by the scientific committees of the French PRM (SOFMER) and Anesthesia and Intensive care (SFAR) societies were invited to work and propose guidelines for the use of loco-regional anesthetic drug for motor nerve blocks in PRM setting. Eight issues were addressed: which neural blocks for which indications; drugs and contraindications; medical survey and attitude in case of adverse event; injection and guidance material; patient preparation and pain relief; efficacy assessment; patient information; education of PRM physiatrists. The Medline, Cochrane and Embase databases for the period 1999 to 2018 were consulted and 355 papers analyzed. The drafts were commented then approved by the whole group using electronic vote, before final approval by scientific committee of each society. Results No scientific evidence emerged from the literature. Thus, these guidelines are mainly based on the opinion of the expert panel. Guidelines for each issue are reported with the main points of arguments. The main question deals with the recommendation about doses for each drug: for lidocaine – up to 2 mg/kg – “check contraindications, emergency truck available, no need of previous anesthetic consultation nor presence of anesthetic physician”; for ropivacaine – up to 1.5 mg/kg, with a maximum of 100 mg – the same but after intravenous line. Beyond these doses, SFAR guidelines have to be applied with the need of anesthetic physician. Conclusion These are the first organizational guidelines devoted to increase the security of motor nerve block use in PRM settings. En ligne : https://www.sciencedirect.com/science/article/pii/S1877065719300739 Permalink : ./index.php?lvl=notice_display&id=84130 [article] French clinical guidelines for peripheral motor nerve blocks in a PRM setting [texte imprimé] / Alain P. Yelnik ; Claire Hentzen ; Philippe Cuvillon ; Etienne Allart ; Isabelle V. Bonan ; François C. Boyer ; Flavia Coroian ; Éric Viel (1931-2008) . - 2019 . - p. 252-264. https://doi.org/10.1016/j.rehab.2019.06.001 Langues : Anglais (eng) in Annals of physical and rehabilitation medicine > Vol. 62, n°4 (Juillet 2019) . - p. 252-264 Mots-clés : Motor nerve block  Physical and rehabilitation medicine  Spasticity  Rehabilitation Résumé : Introduction Motor nerve blocks with anesthetic drug for local anesthesia are commonly used in physical and rehabilitation medicine (PRM), especially in the field of spasticity. Guidelines in this context are currently lacking. Method Eighteen experts selected on the basis of their recognized experience by the scientific committees of the French PRM (SOFMER) and Anesthesia and Intensive care (SFAR) societies were invited to work and propose guidelines for the use of loco-regional anesthetic drug for motor nerve blocks in PRM setting. Eight issues were addressed: which neural blocks for which indications; drugs and contraindications; medical survey and attitude in case of adverse event; injection and guidance material; patient preparation and pain relief; efficacy assessment; patient information; education of PRM physiatrists. The Medline, Cochrane and Embase databases for the period 1999 to 2018 were consulted and 355 papers analyzed. The drafts were commented then approved by the whole group using electronic vote, before final approval by scientific committee of each society. Results No scientific evidence emerged from the literature. Thus, these guidelines are mainly based on the opinion of the expert panel. Guidelines for each issue are reported with the main points of arguments. The main question deals with the recommendation about doses for each drug: for lidocaine – up to 2 mg/kg – “check contraindications, emergency truck available, no need of previous anesthetic consultation nor presence of anesthetic physician”; for ropivacaine – up to 1.5 mg/kg, with a maximum of 100 mg – the same but after intravenous line. Beyond these doses, SFAR guidelines have to be applied with the need of anesthetic physician. Conclusion These are the first organizational guidelines devoted to increase the security of motor nerve block use in PRM settings. En ligne : https://www.sciencedirect.com/science/article/pii/S1877065719300739 Permalink : ./index.php?lvl=notice_display&id=84130

Exemplaires (1)

Cote	Support	Localisation	Section	Disponibilité
Revue	Revue	Centre de Documentation HELHa Campus Montignies	Armoires à volets	Document exclu du prêt - à consulter sur place Exclu du prêt

Time to be Ready to Void: A new tool to assess the time needed to perform micturition for patients with multiple sclerosis / Claire Hentzen in Annals of physical and rehabilitation medicine, Vol. 63, n°2 (Mars 2020)

Public ISBD [article]  inAnnals of physical and rehabilitation medicine > Vol. 63, n°2 (Mars 2020) . - p. 99-105 Titre : Time to be Ready to Void: A new tool to assess the time needed to perform micturition for patients with multiple sclerosis Type de document : texte imprimé Auteurs : Claire Hentzen ; Anaïs Villaumé ; Nicolas Trumel ; Gabriel Miget ; Frédéric Le Breton ; Camille Chesnel ; Gérard Amarenco Année de publication : 2020 Article en page(s) : p. 99-105 Note générale : doi.org/10.1016/j.rehab.2020.01.002 Langues : Anglais (eng) Mots-clés : Multiple sclerosis  Overactive bladder  Urinary incontinence  Urge  Task performance and analysis Résumé : Background Urgency urinary incontinence is one of the major disabling urinary symptoms in people with multiple sclerosis (PwMS). The warning time (time from first sensation of urgency to voiding or incontinence) only partially reflects the possibility of continence. Other factors such as mobility, difficulties in transfer or undressing can influence this time. Objectives The aim was to create a specific test for PwMS to assess the global time required to be ready to perform micturition and to assess its reliability. Methods The Time to be Ready to Void (TRV) was based on 2 timed steps: “mobility” stage, including standing up and walking 6 m to the toilet, and the “settled” stage, starting as soon as the individual opens the toilet door until readiness for micturition. All participants performed the TRV twice. Reliability were assessed by the intraclass correlation coefficient (ICC) and convergent validity by Spearman correlation coefficient. Results We included 71 PwMS (mean [SD] age 54.4 [11.7] years). Inter-rater reliability was excellent for the TRV mobility stage (ICC: 0.97), settled stage (ICC: 0.99) and total test (ICC: 0.99). Test–retest reliability was good for the mobility stage (ICC: 0.88) and total test (ICC: 0.81) and moderate for the settled stage (ICC: 0.67). Test–retest reliability assessed by a Likert-type scale was good for each stage (κ 0.75 and 0.88). The mobility stage was correlated with the scores for the Timed Up and Go test, 10-Meter Walk Test, and Tinetti Mobility Test (ρ = 0.89; ρ = 0.88; ρ = −0.67, respectively; P < 0.0001) and the settled stage with scores for the Tinetti Mobility Test, Functional Independence Measure and Nine Hold Peg test (right) (ρ = −0.48; ρ = −0.36; ρ = 0.31, respectively; P < 0.01). Comprehension, acceptance and relevance were rated good by most participants (97%, 95% and 90%, respectively). Conclusion The TRV is a new tool to measure the global time needed to be ready to achieve micturition in PwMS. It seems useful in clinical practice for overactive bladder in addition to the classical warning time because it takes into account all the time needed to accomplish micturition (mobility, undressing, installation). Permalink : ./index.php?lvl=notice_display&id=90778 [article] Time to be Ready to Void: A new tool to assess the time needed to perform micturition for patients with multiple sclerosis [texte imprimé] / Claire Hentzen ; Anaïs Villaumé ; Nicolas Trumel ; Gabriel Miget ; Frédéric Le Breton ; Camille Chesnel ; Gérard Amarenco . - 2020 . - p. 99-105. doi.org/10.1016/j.rehab.2020.01.002 Langues : Anglais (eng) in Annals of physical and rehabilitation medicine > Vol. 63, n°2 (Mars 2020) . - p. 99-105 Mots-clés : Multiple sclerosis  Overactive bladder  Urinary incontinence  Urge  Task performance and analysis Résumé : Background Urgency urinary incontinence is one of the major disabling urinary symptoms in people with multiple sclerosis (PwMS). The warning time (time from first sensation of urgency to voiding or incontinence) only partially reflects the possibility of continence. Other factors such as mobility, difficulties in transfer or undressing can influence this time. Objectives The aim was to create a specific test for PwMS to assess the global time required to be ready to perform micturition and to assess its reliability. Methods The Time to be Ready to Void (TRV) was based on 2 timed steps: “mobility” stage, including standing up and walking 6 m to the toilet, and the “settled” stage, starting as soon as the individual opens the toilet door until readiness for micturition. All participants performed the TRV twice. Reliability were assessed by the intraclass correlation coefficient (ICC) and convergent validity by Spearman correlation coefficient. Results We included 71 PwMS (mean [SD] age 54.4 [11.7] years). Inter-rater reliability was excellent for the TRV mobility stage (ICC: 0.97), settled stage (ICC: 0.99) and total test (ICC: 0.99). Test–retest reliability was good for the mobility stage (ICC: 0.88) and total test (ICC: 0.81) and moderate for the settled stage (ICC: 0.67). Test–retest reliability assessed by a Likert-type scale was good for each stage (κ 0.75 and 0.88). The mobility stage was correlated with the scores for the Timed Up and Go test, 10-Meter Walk Test, and Tinetti Mobility Test (ρ = 0.89; ρ = 0.88; ρ = −0.67, respectively; P < 0.0001) and the settled stage with scores for the Tinetti Mobility Test, Functional Independence Measure and Nine Hold Peg test (right) (ρ = −0.48; ρ = −0.36; ρ = 0.31, respectively; P < 0.01). Comprehension, acceptance and relevance were rated good by most participants (97%, 95% and 90%, respectively). Conclusion The TRV is a new tool to measure the global time needed to be ready to achieve micturition in PwMS. It seems useful in clinical practice for overactive bladder in addition to the classical warning time because it takes into account all the time needed to accomplish micturition (mobility, undressing, installation). Permalink : ./index.php?lvl=notice_display&id=90778

Exemplaires (1)

Cote	Support	Localisation	Section	Disponibilité
Revue	Revue	Centre de Documentation HELHa Campus Montignies	Armoires à volets	Document exclu du prêt - à consulter sur place Exclu du prêt

---

1 (1 - 3 / 3)